High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: A morphologic study of 55 cases

American Journal of Surgical Pathology

Volumn 33, Issue 4, 2009, Pages 583-890

  Zhao, Jin ^a   Epstein, Jonathan I ^a,b,c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Departments of Urology   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Foamy gland carcinoma; Gleason grading system; Prostate adenocarcinoma

Indexed keywords

CYTOKERATIN 7; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; CANCER INVASION; CHEMISTRY; HUMAN; MALE; MIDDLE AGED; MITOSIS; NEEDLE BIOPSY; NUCLEOLUS; PATHOLOGY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CELL NUCLEOLUS; HUMANS; KERATIN-7; MALE; MIDDLE AGED; MITOSIS; NEOPLASM INVASIVENESS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TRANSURETHRAL RESECTION OF PROSTATE; TUMOR MARKERS, BIOLOGICAL;

EID: 63849160042     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31818a5c6c     Document Type: Article

References (13)

1. Berman DM, Yang J, Epstein JI. Foamy gland high-grade prostatic intraepithelial neoplasia. Am J Surg Pathol. 2000;24:140-144.
2. Eble JN, Sauter G, Epstein JI, et al, eds. Pathology and Genetics: Tumors of the urinary system and male genital organs. WHO classification of tumors. Lyon, France: IARC Press; 2004.
3. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: Implications for patient care. J Urol. 2006;175:820-834.
4. Epstein JI, Allsbrook WC Jr, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228-1242.
5. Gokden N, Roehl KA, Catalona WJ, et al. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: Current level of risk in screening population. Urology. 2005;65:538-542.
6. Googe PB, McGinley KM, Fitzgibbon JF. Anticytokeratin antibody 34 beta E12 staining in prostate carcinoma. Am J Clin Pathol. 1997;107:219-223.
7. Lefkowitz GK, Sidhu GS, Torre P, et al. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology. 2001;58:999-1003.
8. Lefkowitz GK, Taneja SS, Brown J, et al. Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. J Urol. 2002;168:1415-1418.
9. Nelson RS, Epstein JI. Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma. Am J Surg Pathol. 1996;20:419-426.
10. Oliai BR, Kahane H, Epstein JI. Can basal cells be seen in adenocarcinoma of the prostate?: An immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody. Am J Surg Pathol. 2002;26:1151-1160.
11. Osunkoya AO, Hansel DE, Sun X, et al. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: Report of 21 cases. Am J Surg Pathol. 2008; 32:461-467.
12. Schindler S, Usman MI, Yokoo H. Foamy gland carcinoma of the prostate. Am J Surg Pathol. 1997;21:616-618.
13. Tran TT, Sengupta E, Yang XJ. Prostatic foamy gland carcinoma with aggressive behavior: Clinicopathologic, immunohistochemical, and ultrastructural analysis. Am J Surg Pathol. 2001;25: 618-623.